The University of Chicago Header Logo

Host immunity contributes to the anti-melanoma activity of BRAF inhibitors.

Host immunity contributes to the anti-melanoma activity of BRAF inhibitors. J Clin Invest. 2023 Dec 15; 133(24).

View in: PubMed